Adagio Medical (NASDAQ:ADGM) Releases Quarterly Earnings Results, Beats Estimates By $1.47 EPS

Adagio Medical (NASDAQ:ADGM – Get Free Report) issued its earnings results on Monday. The company reported ($5.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($6.60) by $1.47, reports.

Adagio Medical Stock Down 17.0%

Adagio Medical stock opened at $1.60 on Tuesday. The firm has a market capitalization of $44.36 million, a price-to-earnings ratio of -0.04 and a beta of 0.07. The firm’s fifty day moving average price is $6.11 and its two-hundred day moving average price is $21.07. Adagio Medical has a 1-year low of $1.46 and a 1-year high of $50.70. The company has a current ratio of 1.41, a quick ratio of 1.15 and a debt-to-equity ratio of 4.00.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Adagio Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, August 19th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $105.00.

Get Our Latest Stock Report on Adagio Medical

About Adagio Medical

(Get Free Report)

Adagio Medical is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals. The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.

Recommended Stories

Earnings History for Adagio Medical (NASDAQ:ADGM)

Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.